ESGVH (ESCMID Study Group for Viral Hepatitis)
@esgvh.bsky.social
ESGVH is ESCMID's Study Group for Viral Hepatitis. Committed to collaborative excellence in the field of viral hepatitis.
🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫
@escmid.bsky.social
@eacsociety.bsky.social
@escmid.bsky.social
@eacsociety.bsky.social
October 19, 2025 at 9:13 AM
🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫
@escmid.bsky.social
@eacsociety.bsky.social
@escmid.bsky.social
@eacsociety.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Also at #EACS2025 🇫🇷✨
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
October 18, 2025 at 7:55 PM
Also at #EACS2025 🇫🇷✨
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#EACS2025 🇫🇷✨
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
October 18, 2025 at 7:52 PM
#EACS2025 🇫🇷✨
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#EACS2025- Oana Sandulescu is talking about advancing #PrEP equity across #Europe by integrating policy, community and clinical approaches, integrating PrEP delivery, reaching underserved populations, simplifying access and supporting community-led and peer-based models.
October 16, 2025 at 11:18 AM
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
PrEP around Europe.. are we leaving anyone behind? @oana-sandulescu.bsky.social #EACS2025 there are a lot of hidden barriers to Access, are we doing our best to mitigate them?
October 16, 2025 at 9:15 AM
PrEP around Europe.. are we leaving anyone behind? @oana-sandulescu.bsky.social #EACS2025 there are a lot of hidden barriers to Access, are we doing our best to mitigate them?
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
✨ Great start to #EACS2025
🎤 Amazing @tristanjbarber.bsky.social opens the pre-conf Ed Course that features a stellar mix: clinical cases + research 🔍
🧬 Malignancies
🦠 Virology
💭 Stigma
⚖️ Weight
🔮 Future of ART
🎓 Research & Education
Excited for what’s ahead for #YING! 🚀
@eacsociety.bsky.social
🎤 Amazing @tristanjbarber.bsky.social opens the pre-conf Ed Course that features a stellar mix: clinical cases + research 🔍
🧬 Malignancies
🦠 Virology
💭 Stigma
⚖️ Weight
🔮 Future of ART
🎓 Research & Education
Excited for what’s ahead for #YING! 🚀
@eacsociety.bsky.social
October 15, 2025 at 8:54 AM
✨ Great start to #EACS2025
🎤 Amazing @tristanjbarber.bsky.social opens the pre-conf Ed Course that features a stellar mix: clinical cases + research 🔍
🧬 Malignancies
🦠 Virology
💭 Stigma
⚖️ Weight
🔮 Future of ART
🎓 Research & Education
Excited for what’s ahead for #YING! 🚀
@eacsociety.bsky.social
🎤 Amazing @tristanjbarber.bsky.social opens the pre-conf Ed Course that features a stellar mix: clinical cases + research 🔍
🧬 Malignancies
🦠 Virology
💭 Stigma
⚖️ Weight
🔮 Future of ART
🎓 Research & Education
Excited for what’s ahead for #YING! 🚀
@eacsociety.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
A truly insightful exchange of knowledge with outstanding experts at the ESCMID #VaccinesConference
@escmid.bsky.social
Gulsen Ozkaya Sahin
@casandrabulescu.bsky.social
Susanne Gjeruldsen Dudman
@oana-sandulescu.bsky.social
Zeinab Nabil
Mario Mondelli
@taescmid.bsky.social
@esgvh.bsky.social
@escmid.bsky.social
Gulsen Ozkaya Sahin
@casandrabulescu.bsky.social
Susanne Gjeruldsen Dudman
@oana-sandulescu.bsky.social
Zeinab Nabil
Mario Mondelli
@taescmid.bsky.social
@esgvh.bsky.social
Inspiring session at the ESCMID #VaccinesConference! 🌍
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
September 12, 2025 at 12:46 PM
A truly insightful exchange of knowledge with outstanding experts at the ESCMID #VaccinesConference
@escmid.bsky.social
Gulsen Ozkaya Sahin
@casandrabulescu.bsky.social
Susanne Gjeruldsen Dudman
@oana-sandulescu.bsky.social
Zeinab Nabil
Mario Mondelli
@taescmid.bsky.social
@esgvh.bsky.social
@escmid.bsky.social
Gulsen Ozkaya Sahin
@casandrabulescu.bsky.social
Susanne Gjeruldsen Dudman
@oana-sandulescu.bsky.social
Zeinab Nabil
Mario Mondelli
@taescmid.bsky.social
@esgvh.bsky.social
Inspiring session at the ESCMID #VaccinesConference! 🌍
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
September 12, 2025 at 12:43 PM
Inspiring session at the ESCMID #VaccinesConference! 🌍
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
This morning's hepatitis elimination session featured expertly delivered presentations from @esgvh.bsky.social members @oana-sandulescu.bsky.social, Susanne Dudman, Zeinab Nabil, and Mario Mondelli. An insightful morning 👏
@escmid.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
✨ Day 3 at @escmid.bsky.social #VaccinesConference
Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision?
Fascinating fresh perspectives from international experts 🌍
Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨
Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision?
Fascinating fresh perspectives from international experts 🌍
Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨
September 12, 2025 at 9:33 AM
✨ Day 3 at @escmid.bsky.social #VaccinesConference
Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision?
Fascinating fresh perspectives from international experts 🌍
Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨
Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision?
Fascinating fresh perspectives from international experts 🌍
Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Break time is networking time at the #VaccinesConference! Day 2 kicked off with a session on #vaccines against gastrointestinal infections and some great abstract presentations. Now attendees can enjoy a short break before the next set of sessions start focused on #OneHealth. #IDsky
September 11, 2025 at 8:38 AM
Break time is networking time at the #VaccinesConference! Day 2 kicked off with a session on #vaccines against gastrointestinal infections and some great abstract presentations. Now attendees can enjoy a short break before the next set of sessions start focused on #OneHealth. #IDsky
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith.
@ema.europa.eu #VaccinesConference #Vaccines #IDSky
@ema.europa.eu #VaccinesConference #Vaccines #IDSky
September 11, 2025 at 11:10 AM
Fantastic session on vaccine licensing covering aspects from fighting ongoing outbreaks, limited clinical data, and the current latest developments in the pipeline. Featuring Marco Cavaleri, Sarah Gilbert, Teresa Lambe and Annelies Wilder-Smith.
@ema.europa.eu #VaccinesConference #Vaccines #IDSky
@ema.europa.eu #VaccinesConference #Vaccines #IDSky
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Delighted to have chaired this session at the #VaccinesConference by @escmid.bsky.social
Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬
Now up, a thought provoking keynote lecture.
Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬
Now up, a thought provoking keynote lecture.
September 11, 2025 at 4:53 PM
Delighted to have chaired this session at the #VaccinesConference by @escmid.bsky.social
Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬
Now up, a thought provoking keynote lecture.
Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬
Now up, a thought provoking keynote lecture.
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
A pleasure to be part of the scientific committee for this event.
Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research.
amededu.co/45sJDE0
Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research.
amededu.co/45sJDE0
July 30, 2025 at 2:53 PM
A pleasure to be part of the scientific committee for this event.
Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research.
amededu.co/45sJDE0
Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research.
amededu.co/45sJDE0
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Today is #WorldHepatitisDay!
Let's break down all the obstacles hindering the elimination of viral hepatitis.
Read our president's address!
www.worldhepatitisalliance.org/news/world-h...
Let's break down all the obstacles hindering the elimination of viral hepatitis.
Read our president's address!
www.worldhepatitisalliance.org/news/world-h...
July 28, 2025 at 11:16 AM
Today is #WorldHepatitisDay!
Let's break down all the obstacles hindering the elimination of viral hepatitis.
Read our president's address!
www.worldhepatitisalliance.org/news/world-h...
Let's break down all the obstacles hindering the elimination of viral hepatitis.
Read our president's address!
www.worldhepatitisalliance.org/news/world-h...
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Research is crucial to inform better interventions for #diagnosis, #prevention & #treatment of viral #hepatitis for different people in different settings. Global collaboration essential!
#WorldHepatitisDay #NoHep #HBV
@crick.ac.uk @ahri-news.bsky.social @cnwl.nhs.uk @ucllifesciences.bsky.social
🧪
#WorldHepatitisDay #NoHep #HBV
@crick.ac.uk @ahri-news.bsky.social @cnwl.nhs.uk @ucllifesciences.bsky.social
🧪
July 28, 2025 at 11:16 AM
Research is crucial to inform better interventions for #diagnosis, #prevention & #treatment of viral #hepatitis for different people in different settings. Global collaboration essential!
#WorldHepatitisDay #NoHep #HBV
@crick.ac.uk @ahri-news.bsky.social @cnwl.nhs.uk @ucllifesciences.bsky.social
🧪
#WorldHepatitisDay #NoHep #HBV
@crick.ac.uk @ahri-news.bsky.social @cnwl.nhs.uk @ucllifesciences.bsky.social
🧪
🟡Today is #WorldHepatitisDay
@esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment.
🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social?
👉Replay now: lnkd.in/dmJKN85U
#Hepatitis #WHD2025
@escmid.bsky.social
@esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment.
🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social?
👉Replay now: lnkd.in/dmJKN85U
#Hepatitis #WHD2025
@escmid.bsky.social
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
July 28, 2025 at 3:37 PM
🟡Today is #WorldHepatitisDay
@esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment.
🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social?
👉Replay now: lnkd.in/dmJKN85U
#Hepatitis #WHD2025
@escmid.bsky.social
@esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment.
🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social?
👉Replay now: lnkd.in/dmJKN85U
#Hepatitis #WHD2025
@escmid.bsky.social
📢 Call to young researchers:
On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research.
If you are an early career MD, fill out the survey below:
lnkd.in/dkQbmWqQ
@escmid.bsky.social
On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research.
If you are an early career MD, fill out the survey below:
lnkd.in/dkQbmWqQ
@escmid.bsky.social
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
July 18, 2025 at 1:55 PM
📢 Call to young researchers:
On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research.
If you are an early career MD, fill out the survey below:
lnkd.in/dkQbmWqQ
@escmid.bsky.social
On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research.
If you are an early career MD, fill out the survey below:
lnkd.in/dkQbmWqQ
@escmid.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
🚨 Call for Papers!
Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️
Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2)
Submit you work on chronic illness, travel prep, vaccines, & more.
📩 Info: bit.ly/3EBo9Kw
#TravelMedicine
@springernature.com
Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️
Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2)
Submit you work on chronic illness, travel prep, vaccines, & more.
📩 Info: bit.ly/3EBo9Kw
#TravelMedicine
@springernature.com
July 11, 2025 at 12:21 PM
🚨 Call for Papers!
Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️
Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2)
Submit you work on chronic illness, travel prep, vaccines, & more.
📩 Info: bit.ly/3EBo9Kw
#TravelMedicine
@springernature.com
Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️
Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2)
Submit you work on chronic illness, travel prep, vaccines, & more.
📩 Info: bit.ly/3EBo9Kw
#TravelMedicine
@springernature.com
🚨 Today!
💡 High-level webinar
📢 World Hepatitis Day 2025 – Viral hepatitis cannot wait!
Join a milestone event co-organized by:
🔹 ESGVH
🔹 ECDC
🔹 WHO Europe
🔹 WHA
📅 Today, 3 July 2025
🕚 11:00–12:00 CET
🔗 Register now:
lnkd.in/dUipyqcp
@esgvh.bsky.social @oana-sandulescu.bsky.social
💡 High-level webinar
📢 World Hepatitis Day 2025 – Viral hepatitis cannot wait!
Join a milestone event co-organized by:
🔹 ESGVH
🔹 ECDC
🔹 WHO Europe
🔹 WHA
📅 Today, 3 July 2025
🕚 11:00–12:00 CET
🔗 Register now:
lnkd.in/dUipyqcp
@esgvh.bsky.social @oana-sandulescu.bsky.social
July 3, 2025 at 6:08 AM
🚨 Today!
💡 High-level webinar
📢 World Hepatitis Day 2025 – Viral hepatitis cannot wait!
Join a milestone event co-organized by:
🔹 ESGVH
🔹 ECDC
🔹 WHO Europe
🔹 WHA
📅 Today, 3 July 2025
🕚 11:00–12:00 CET
🔗 Register now:
lnkd.in/dUipyqcp
@esgvh.bsky.social @oana-sandulescu.bsky.social
💡 High-level webinar
📢 World Hepatitis Day 2025 – Viral hepatitis cannot wait!
Join a milestone event co-organized by:
🔹 ESGVH
🔹 ECDC
🔹 WHO Europe
🔹 WHA
📅 Today, 3 July 2025
🕚 11:00–12:00 CET
🔗 Register now:
lnkd.in/dUipyqcp
@esgvh.bsky.social @oana-sandulescu.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
We are at the @europarl.europa.eu for the EP Roundtable hosted by MEP @krzysztofsmiszek.bsky.social
Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.
Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.
June 30, 2025 at 1:20 PM
We are at the @europarl.europa.eu for the EP Roundtable hosted by MEP @krzysztofsmiszek.bsky.social
Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.
Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
The Emerging Infections Subcommittee launches ESCMID-AUMC Epi Alert! Aiming for weekly publication, these reports aim to provide summaries on emerging infections for busy healthcare professionals w/ direct links for further investigation & transparency. ow.ly/5Rrj50WcejS
#IDSky #clinmicro
#IDSky #clinmicro
June 20, 2025 at 9:53 AM
The Emerging Infections Subcommittee launches ESCMID-AUMC Epi Alert! Aiming for weekly publication, these reports aim to provide summaries on emerging infections for busy healthcare professionals w/ direct links for further investigation & transparency. ow.ly/5Rrj50WcejS
#IDSky #clinmicro
#IDSky #clinmicro
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Help shape #EASLCongress 2026! We’re gathering input from the hepatology community to build a relevant, inclusive, and impactful programme. Share your insights in our short survey + enter to win free registration. 👉 www.surveymonkey.com/r/6F9BRBD
June 24, 2025 at 6:49 AM
Help shape #EASLCongress 2026! We’re gathering input from the hepatology community to build a relevant, inclusive, and impactful programme. Share your insights in our short survey + enter to win free registration. 👉 www.surveymonkey.com/r/6F9BRBD
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
📰 If you are looking to publish with one of ESCMID's journals
💡Did you know: Our publisher, Elsevier, holds agreements w/ selected academic institutions that could make you eligible for waiving open access fees...meaning you could publish for free.
Learn more: www.elsevier.com/ope...
#IDSky
💡Did you know: Our publisher, Elsevier, holds agreements w/ selected academic institutions that could make you eligible for waiving open access fees...meaning you could publish for free.
Learn more: www.elsevier.com/ope...
#IDSky
Open access agreements | Elsevier
Elsevier has reached open access agreements with several institutions. See the full list.
www.elsevier.com
June 22, 2025 at 1:35 PM
📰 If you are looking to publish with one of ESCMID's journals
💡Did you know: Our publisher, Elsevier, holds agreements w/ selected academic institutions that could make you eligible for waiving open access fees...meaning you could publish for free.
Learn more: www.elsevier.com/ope...
#IDSky
💡Did you know: Our publisher, Elsevier, holds agreements w/ selected academic institutions that could make you eligible for waiving open access fees...meaning you could publish for free.
Learn more: www.elsevier.com/ope...
#IDSky
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
⌛Last chance to apply for attendance grants for the postgraduate course on 'Better methods'. Apply by 30 June!
🗓️ Athens, Greece, 28-30 Oct 🍂
💡More info: ow.ly/7mnN50VWeUy
#IDSky #clinmicro #MedSky
🗓️ Athens, Greece, 28-30 Oct 🍂
💡More info: ow.ly/7mnN50VWeUy
#IDSky #clinmicro #MedSky
June 25, 2025 at 7:55 AM
⌛Last chance to apply for attendance grants for the postgraduate course on 'Better methods'. Apply by 30 June!
🗓️ Athens, Greece, 28-30 Oct 🍂
💡More info: ow.ly/7mnN50VWeUy
#IDSky #clinmicro #MedSky
🗓️ Athens, Greece, 28-30 Oct 🍂
💡More info: ow.ly/7mnN50VWeUy
#IDSky #clinmicro #MedSky
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#DKY that in our post-grad course you can choose between two tracks, join parallel workshops, discuss real-world cases, & network with your peers? 💡
👀Check out the programme, apply for an attendance grant, or register directly to secure your place!
➡️ bit.ly/44a1tdn
#IDSky #ResearchSky #Education
👀Check out the programme, apply for an attendance grant, or register directly to secure your place!
➡️ bit.ly/44a1tdn
#IDSky #ResearchSky #Education
June 18, 2025 at 7:42 AM
#DKY that in our post-grad course you can choose between two tracks, join parallel workshops, discuss real-world cases, & network with your peers? 💡
👀Check out the programme, apply for an attendance grant, or register directly to secure your place!
➡️ bit.ly/44a1tdn
#IDSky #ResearchSky #Education
👀Check out the programme, apply for an attendance grant, or register directly to secure your place!
➡️ bit.ly/44a1tdn
#IDSky #ResearchSky #Education